Dr. Pinto earned his Ph.D. in Bioengineering from Northern Arizona University in the Tissue Engineering and Regenerative Medicine Laboratory of Dr. Robert S. Kellar. His academic research focused on wound healing, environmental toxicology, and the development of bioengineered wound healing constructs for the treatment of chronic wounds. His work was funded by multiple NIH grants that focused on underrepresented minorities, environmental toxicology, and wound healing. Dr. Pinto holds an adjunct faculty position at Coconino Community College where he teaches Human Anatomy and Physiology and Introduction to Biology.
Dr. Pinto is Co-founder and Chief Science Officer of Amnyo, LLC, a regenerative biologics company, and co-founder and Chief Science Officer of Skinventive, a cosmetic manufacturer. Prior to starting his two companies, Dr. Pinto worked as an independent contractor for Development Engineering Sciences in Flagstaff, Arizona. He worked on various projects involving cell culture, endovascular stent and graft technology, histopathology, immunohistochemistry, quantitative polymerase chain reaction, topical skin formulation, platelet-rich plasma creation, and integumentary wound healing device prototyping and optimization. After his time at Development Engineering Sciences, Dr. Pinto began working as a Research and Development Scientist for Axolotl Biologix in Phoenix, Arizona. He contributed to the development and commercialization of birth tissue-derived regenerative products used to treat chronic wounds and joint degeneration.